journal article·2009-06

Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release

Aiping Zhu, Lanhua Yuan, Wenjie Jin, Sheng Dai, Qianqian Wang, Zhengfeng Xue, Aijian Qin

Acta Biomaterialia· Volume 5· Issue 5
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Transport and Resistance Mechanisms · Protein Interaction Studies and Fluorescence Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Nanostructured materials in solid state ionics10.1016/S0167-2738(00)00324-6 ↗
2. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system10.1016/j.jmmm.2005.01.064 ↗
3. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake10.1016/S0142-9612(01)00267-8 ↗
4. Intracellular labeling of T-cells with superparamagnetic contrast agents10.1002/mrm.1910300513 ↗
5. Measuring transferring receptor gene expression by NMR imaging10.1016/S0167-4889(98)00002-0 ↗
6. Magnetically labeled cells can be detected by MR imaging10.1002/jmri.1880070140 ↗
7. Synthesis of oligonucleotide functionalized magnetic nanoparticles and study on their in vitro cell uptake10.1002/aoc.752 ↗
8. News focus—nanomaterials show signs of toxicity10.1126/science.300.5617.243a ↗
9. Noninvasive imaging of quantum dots in mice10.1021/bc034153y ↗
10. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo10.1126/science.1083780 ↗
11. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cell10.1021/la0503451 ↗
12. Receptor-mediated delivery of trans-retinoic acid to hepatocyte using poly (l-lactic acid) nanoparticles coated with galactose-carrying polystyrene10.1016/S0168-3659(01)00390-X ↗
13. Iron oxide nanoparticles for sustained delivery of anticancer agents10.1021/mp0500014 ↗
14. Locoregional cancer treatment with magnetic drug targeting
15. Antibody-magnetic nanoparticles: in vitro characterization of potential tumor-specific contrast agent for magnetic resonance imaging10.1021/bc00023a007 ↗
16. A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer10.1088/0957-4484/15/5/009 ↗
17. Applications of magnetic targeting in diagnosis and therapy—possibilities and limitations: a mini-review10.1089/hyb.1997.16.109 ↗
19. Fussel F, Dissertation, Aachen: Rheinsch-Westfalische Technische Hochschule Aachen; 1997.
20. Protective coating of superparamagnetic iron oxide nanoparticles10.1021/cm021349j ↗
21. Chemical modification of chitosan, synthesis of organosoluble, palladium adsorbable, and biodegradable chitosan derivatives toward the chemical plating on plastics10.1021/bm0200478 ↗
22. Preparation of the well-disperse superparamagnetic iron oxide nanoparticles in an aqueous solution with biocompatible N-succinyl-O-carboxymethylchitosan10.1021/jp711319a ↗
23. Suspension of Fe3O4 nanoparticles stabilized by chitosan and O-carboxymethylchitosan10.1016/j.ijpharm.2007.09.004 ↗
24. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system10.1016/0169-409X(95)00039-A ↗
25. Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters10.1021/bc0340013 ↗
26. Nanoparticles in cancer therapy and diagnosis10.1016/S0169-409X(02)00044-3 ↗
27. Preparation of the well-disperse effective loading and controlled release of camptothecin by O-carboxymethylchitosan aggregates10.1016/j.carbpol.2005.08.006 ↗
28. Interaction between O-carboxymethylchitosan and dipalmitoyl-sn-glycero-3-phosphocholine bilayer10.1016/j.biomaterials.2005.05.021 ↗
29. The aggregation behavior of O-carboxymethylchitosan in dilute aqueous solution10.1016/j.colsurfb.2005.04.009 ↗
30. Synthesis and aggregation behavior of N-succinyl-O-carboxymethylchitosan in aqueous solutions10.1007/s00396-007-1716-7 ↗
31. Incorporation and release behavior of hydrophobic drug in functionalized poly(d,l-lactide)-block-poly(ethylene oxide) micelles10.1016/j.jconrel.2003.10.012 ↗
32. Nano-engineering block copolymer aggregates for drug delivery10.1016/S0927-7765(99)00058-2 ↗
33. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice10.1016/j.jconrel.2007.02.013 ↗
34. Characterization of protein release from photocrosslinkable hyaluronic acid–polyethylene glycol hydrogel tissue engineering scaffolds10.1016/j.biomaterials.2004.02.018 ↗
35. Structure–activity study of the actions of camptothecin derivatives on mammalian topoisomerase. I: Evidence for a specific receptor site and for a relation to antitumor activity
36. Magnetic nanoparticle design for medical, diagnosis and therapy10.1039/b402025a ↗
37. Current perspectives on the clinical experience, pharmacology and continued development of the camptothecins
38. The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance10.1002/jbm.a.30901 ↗
39. Effect of chitosan on the permeability of monolayers of intestinal epithelial epithelial-cells (CACO-2)10.1023/A:1018967116988 ↗